1869P Risk factors for reduced relative dose intensity (RDI) in patients with solid tumors receiving chemotherapy (CT) and primary prolonged G-CSF prophylaxis by empegfilgrastim: Analysis of DEFENDOR study

Saved in:

Bibliographic Details
Published in	Annals of oncology Vol. 35; pp. S1097 - S1098
Main Authors	Snegovoy, A., Kononenko, I.B., Sorokina, I., Kiseleva, P., Mironenko, O., Berezina, A., Prosianikova, O.
Format	Journal Article
Language	English
Published	Elsevier Ltd 01.09.2024
Online Access	Get full text

Loading…

More Information
ISSN:	0923-7534
DOI:	10.1016/j.annonc.2024.08.1963